The company says it has leveraged its expertise in ultrasonic drug delivery to develop a device intended for non-pharmaceutical, topical use with cosmetics. The U-Wand utilizes ultrasound to enhance the penetration and effect of various cosmetics.
The research project is working on the development of four distinct design concepts for the U-Wand, depending on the individual application.
Two of these target larger application areas for the entire body; one is intended for facial application while the fourth is a hybrid model for both face and large area application. The models are either battery powered or charged by a removable power cord.
The delivery system will aim to enhance the efficacy of a variety of topical cosmetic and personal creams, ranging from skin care products such as anti-aging and sun care products to foundation and anti-cellulite products.
Dermisonics says that the introduction of the U-Wand represents entry into an entirely new market opportunity for the company in the realm of consumer products with an initial focus on cosmetics.
Bruce Haglund, chairman and CEO of Dermisonics said, "We believe the application of our ultrasound technology to cosmetics represents a significant new opportunity. Our purpose is to develop innovative methods for the application of cosmetics and to foster their acceptance and use by consumers. We also hope to use these innovative devices as a platform to form a strategic alliance with a major cosmetics company."
The cosmetics delivery system is a new departure for the company, which to date has specialized in medical devices, primarily for the development, testing and eventual commercialization of a transdermal patch designed to facilitate the needle-free delivery of heavy molecular drugs into the system.